Accès à distance ? S'identifier sur le proxy UCLouvain
Organ and tumor dosimetry of Lu-177-DOTA-Tyr(3)-octreotate (Lu-TATE) and Y-90-DOTA-Tyr(3)-octreotide (Y-TOC): A preliminary study in 2 patients.
Primary tabs
Document type | Communication à un colloque (Conference Paper) – Abstract, Présentation orale avec comité de sélection |
---|---|
Publication date | 2002 |
Language | Anglais |
Journal information | "The Journal of Nuclear Medicine" - Vol. 43, no. 5, p. 316P-316P (2002) |
Peer reviewed | yes |
issn | 0161-5505 |
e-issn | 1535-5667 |
Publisher | Soc Nuclear Medicine Inc (Reston) |
Affiliations |
UCL
- Cliniques universitaires Saint-Luc UCL - MD/MINT - Département de médecine interne |
Links |
Bibliographic reference | Kooij, P ; Pauwels, Stanislas ; Kwekkeboom, D ; Walrand, Stephan ; Konijnenberg, M ; et. al. Organ and tumor dosimetry of Lu-177-DOTA-Tyr(3)-octreotate (Lu-TATE) and Y-90-DOTA-Tyr(3)-octreotide (Y-TOC): A preliminary study in 2 patients..In: The Journal of Nuclear Medicine, Vol. 43, no. 5, p. 316P-316P (2002) |
---|---|
Permanent URL | http://hdl.handle.net/2078.1/61780 |